UTS site search

Sheena Arora


Sheena Arora is a Research Fellow at CHERE. She has a background in economics and a Master’s degree in Public Health (specialising in health economics), from the University of Sydney. She has been involved in various public health research projects, including the coordination of a large scale randomised controlled trial for the Centre for Medical Psychology and Evidence Based Decision Making (CEMPED), and most recently, as a project coordinator at the National Drug and Alcohol Research Centre (NDARC). She also has teaching experience, teaching epidemiology to postgraduate students at the University of Sydney.

Image of Sheena Arora
Research Fellow, Centre for Health Economics Research and Evaluation
Core Member, CHERE - Centre for Health Economics and Research Evaluation
Bachelor of Commerce/Science, Masters of Public Health
+61 2 9514 4744


Arora, S., Goodall, S., Einfeld, S. & Viney, R. 2016, 'Using Discrete Choice experiments to value informal care provided to children with intellectual disabilities', ISPOR 7th Asia-Pacific Conference, Singapore.
Arora, S., Goodall, S., Viney, R. & Einfeld, S. 2016, 'Using a discrete choice experiment to value informal care provided to children with intellectual disabilities', 38th Annual Australian Health Economics Society Conference, Perth.
Reeve, R., Butler, K., Burns, L., Viney, R.C., Arora, S., Goodall, S. & van Gool, K. 2015, 'Using multi-methods to evaluate clinical services: A case study', International Evaluation Conference, Melbourne.
Reeve, R., Butler, K., Burns, L., Viney, R.C., Arora, S., Goodall, S. & van Gool, K. 2015, 'The costs and consequences of targeting AOD patients presenting to Hospital Emergency Departments', APSAD Annual Scientific Alcohol and Drug Conference, Perth.
Arora, S., Kecmanovic, M., Hall, J.P. & Goodall, S. 2013, 'The impact of financial incentives on primary care in Australia', iHEA 9th World Congress on Health Economics, Sydney.
Kecmanovic, M., Arora, S., Hall, J.P. & Goodall, S. 2013, 'The impact of financial incentives on primary care in Australia', 2013 Primary Health Care Research Conference, Sydney.

Journal articles

Butler, K., Reeve, R., Arora, S., Viney, R., Goodall, S., van Gool, K. & Burns, L. 2016, 'The hidden costs of drug and alcohol use on hospital emergency departments', Drug and Alcohol Review, vol. 35, no. 3, pp. 359-366.
View/Download from: Publisher's site
Reeve, R., Arora, S., Butler, K., Viney, R., Burns, L., Goodall, S. & van Gool, K. 2016, 'Evaluating the impact of hospital based drug and alcohol consultation liaison services', Journal of Substance Abuse Treatment, vol. 68, pp. 36-45.
View/Download from: Publisher's site
Arora, S., Roxburgh, A., Bruno, R., Nielsen, S. & Burns, L. 2013, 'A cross-sectional analysis of over-the-counter codeine use amongst an Australian sample of people who regularly inject drugs', Drug and Alcohol Review, vol. 32, no. 6, pp. 574-581.
View/Download from: UTS OPUS or Publisher's site
Introduction and Aims. The study aims to examine the medical and non-medical use of over-the-counter (OTC) codeine combination drugs in a sample of people who inject drugs; and to examine risk factors associated with exceeding therecommended dose of OTC codeine, including the experience of pain. Design and Methods. This study analysed annual survey data from a convenience sample of people who inject drugs in Australia who are interviewed for the Illicit Drug Reporting System. People who have injected drugs (n = 902) on at least a monthly basis in the preceding six months across Australia were interviewed.Participants were asked about their use of OTC codeine and their experience of pain. Results. One third (35%) of participants had used OTC codeine in the preceding six months and 52% (95% confidence interval 48.755.3) of this group had exceeded the recommended dose on their last occasion of use.This clearly places them at increased risk of harms associated with toxicity from the accompanying analgesic found in combination codeine products. Multivariate analyses demonstrated that those exceeding the recommended codeine dose of OTC codeine were more likely to be experiencing moderate to very severe pain. Discussion and Conclusion. There is a need to evaluate the approach to pain management in this population. Greater pharmacist involvement, real-time monitoring of sales, the development of screening tools to identify those at risk of harm and further education of primary care practitioners could be beneficial in reducing the risk of harm associated with these medications for all users of OTC codeine, including people who inject drugs.
Dear, R., Barratt, A., Askie, L., McGeechan, K., Arora, S., Crossing, S., Currow, D. & Tattersall, M. 2011, 'Adding value to clinical trial registries: insights from Australian Cancer Trials Online, a website for consumers', CLINICAL TRIALS, vol. 8, no. 1, pp. 70-76.
View/Download from: Publisher's site


Arora, S. & Burns, L. NDARC 2012, Australian Capital Territory Drug Trends 2011. Findings from the Illicit Drug Reporting System (IDRS). Australian Drug Trend Series No. 75, pp. 1-88, Sydney.
Arora, S. & Burns, L. NDARC 2012, ACT trends in ecstasy and related drug markets 2011: Findings from the Ecstasy and Related Drugs Reporting System (EDRS). Australian Drug Trends Series No. 84, pp. 1-93, Sydney.